Innovative Biotech Focus Flow Pharma specializes in engineering and manufacturing advanced biomedicines with patented delivery systems, offering targeted treatments for serious diseases like COVID-19, Ebola, and resistant cancers. This positions the company as a potential partner for organizations seeking innovative therapeutic solutions.

Recent Funding Growth The company secured $1.15 million in equity financing in 2018, indicating active investor interest and potential for growth opportunities, making it an attractive prospect for collaborations or investment.

Small but Niche With a small team of 2-10 employees and revenue between 1 million to 10 million, Flow Pharma operates in a specialized market, providing opportunities for tailored partnerships and bespoke solutions rather than mass-market sales.

Technology-Driven Approach Leveraging cloud services like Amazon Web Services, Cloudflare, and multimedia tools indicates a tech-savvy company that values innovation, opening doors for technology partnerships or integration of digital solutions.

Market Expansion Potential Aligning with larger pharmaceutical leaders such as Moderna or Pfizer, Flow Pharma’s focus on cutting-edge treatments positions it to become a key supplier or collaborator in expanding biotech portfolios targeting high-impact diseases.